Anthony Feher, MD
Orthopaedic Surgery · Carmel, INNPI 1932177821
Payments from drug & device makers
Across 72 payments — averaging $288.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$13K
- Depuy Synthes Products, Inc.$3K
- Stryker$2K
- Smith+Nephew$503
- Encore Medical, LP$408
- Zimmer Biomet$249
- plus $844 from 12 others
What the payments were for
- Consulting fees$3,15041%
- Travel & lodging$1,90625%
- Food & beverage$2,70835%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 6 | $13,040 |
| Depuy Synthes Products, Inc. | 4 | $3,232 |
| Stryker | 22 | $2,488 |
| Smith+Nephew | 11 | $503 |
| Encore Medical, LP | 5 | $408 |
| Zimmer Biomet | 5 | $249 |
| Osteoremedies, LLC | 2 | $229 |
| Heraeus Medical, LLC. | 5 | $172 |
| KCI USA, Inc. | 1 | $83 |
| Onkos Surgical, Inc. | 1 | $78 |
| Heron Therapeutics, Inc. | 1 | $62 |
| Medacta USA, Inc. | 2 | $46 |
| TELA Bio, Inc. | 1 | $39 |
| Medtronic | 2 | $35 |
| Johnson & Johnson | 1 | $33 |
| Bioventus LLC | 1 | $29 |
| Exactech, Inc. | 1 | $18 |
| Solventum Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ATTUNE$3,150
- MAKO$2,019
- DJO SURGICAL$399
- ROSA$288
- REAL INTELLIGENCE$148
- Journey II$148
- Legion Revision$148
- Journey Uni$145
- PALACOS$119
How this compares
$20,764 in reported general payments places this provider in the 75th percentile of 400 orthopaedic surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 61 | $2,105 |
| Oxycodone Hcl | 114 | $826 |
| Cefadroxil | 95 | $692 |
| Omeprazole | 88 | $609 |
| Doxycycline Hyclate | 21 | $273 |
| Tramadol Hcl | 14 | $66 |
| Amoxicillin | 28 | $30 |
| Meloxicam | 13 | $20 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Carmel
- Jeffery PiersonCarmel$237K
- Philip HuangCarmel$182K
- Bryan SaltzmanCarmel$156K
- Robert MalinzakCarmel$119K
- Zachary NapierCarmel$87K
- Jason YeCarmel$83K
- Joseph HareCarmel$56K
- Stephen JacobsenCarmel$48K
- Jeffrey KonopkaCarmel$44K
- Frank KolisekGreenwood$7.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.